MYC and Burkitt lymphoma: Here, we report that in Burkitt lymphoma the MYC oncogene can be targeted indirectly through inhibition of the HSP90 machinery, leading to both downregulation of MYC transcription and decreasing MYC protein stability, resulting in diminished tumor cell proliferation through cell cycle arrest, necrosis and apoptosis.